Femke Christina Ching-Chuan van Rhijn-Brouwer

5PUBLICATIONS
4CO-AUTHORS
Predictive and prognostic markersSports science and exercise not elsewhere classifiedCardiovascular medicine and haematology not elsewhere classifiedRespiratory diseasesRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 15, 2024
Systematic review and meta-analysis of the effect of bone marrow-derived cell therapies on hind limb perfusion.

Femke Christina Ching-Chuan van Rhijn-Brouwer, Kimberley Elaine Wever, Romy Kiffen

|Jan 26, 2024
Graded exercise therapy should not be recommended for patients with post-exertional malaise.

Femke Christina Ching-Chuan van Rhijn-Brouwer, Merel Hellemons, Michael Stingl

|Feb 14, 2022
Human Bone Marrow Mononuclear Cells Do Not Improve Limb Perfusion in the Hindlimb Ischemia Model.

Femke Christina Ching-Chuan van Rhijn-Brouwer, Hendrik Gremmels, Krista Den Ouden

|Jan 20, 2022
Evaluation of bone marrow-derived cell-based therapies in the hindlimb ischaemia model: a protocol for a systematic review and meta-analysis.

Femke Christina Ching Chuan van Rhijn-Brouwer, Robin Wilhelmus Maria Vernooij, Kimberley Wever

|Jan 15, 2020
Paracrine Proangiogenic Function of Human Bone Marrow-Derived Mesenchymal Stem Cells Is Not Affected by Chronic Kidney Disease.

Femke C C van Rhijn-Brouwer, Bas W M van Balkom, Diana A Papazova

Pageof 1